Title: Plasma insulin-like growth factor I and prostate cancer risk: A prospective study Author(s): Chan, J. M.; Stampfer, M. J.; Giovannucci, E.; et al. Source: Science Volume: 279 Issue: 5350 Pages: 563-566 Published: 1998 Times Cited: 1334 DOI: 10.1126/science.279.5350.563
added
01-Dec-11
2.
Title: Circulating concentrations of insulin-like growth factor-I and risk of breast cancer Author(s): Hankinson, S. E.; Willett, W. C.; Colditz, G. A.; et al. Source: Lancet Volume: 351 Issue: 9113 Pages: 1393-1396 Published: 1998 Times Cited: 1159 DOI: 10.1016/s0140-6736(97)10384-1
added
17-Jan-12
3.
Title: Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3 Author(s): Ma, J.; Pollak, M. N.; Giovannucci, E.; et al. Source: Journal of the National Cancer Institute Volume: 91 Issue: 7 Pages: 620-625 Published: 1999 Times Cited: 702 DOI: 10.1093/jnci/91.7.620
added
01-Dec-11
4.
Title: Insulin-like growth factors and neoplasia Author(s): Pollak, M. N.; Schernhammer, E. S.; Hankinson, S. E. Source: Nature Reviews Cancer Volume: 4 Issue: 7 Pages: 505-518 Published: 2004 Times Cited: 636 DOI: 10.1038/nrc1387
added
01-Dec-11
5.
Title: Anastrozole is superior to tamoxifen as first-line therapy for advanced breast cancer in postmenopausal women: Results of a North American multicenter randomized trial Author(s): Nabholtz, J. M.; Buzdar, A.; Pollak, M.; et al. Source: Journal of Clinical Oncology Volume: 18 Issue: 22 Pages: 3758-3767 Published: 2000 Times Cited: 550
added
01-Dec-11
6.
Title: Insulin and insulin-like growth factor signalling in neoplasia Author(s): Pollak, Michael Source: Nature Reviews Cancer Volume: 8 Issue: 12 Pages: 915-928 Published: 2008 Times Cited: 537 DOI: 10.1038/nrc2536
added
01-Dec-11
7.
Title: Insulin-like growth factor-I receptor signaling and resistance to trastuzumab (Herceptin) Author(s): Lu, Y. H.; Zi, X. L.; Zhao, Y. H.; et al. Source: Journal of the National Cancer Institute Volume: 93 Issue: 24 Pages: 1852-1857 Published: 2001 Times Cited: 451 DOI: 10.1093/jnci/93.24.1852
added
01-Dec-11
8.
Title: Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells Author(s): Zakikhani, Mahvash; Dowling, Ryan; Fantus, I. George; et al. Source: Cancer Research Volume: 66 Issue: 21 Pages: 10269-10273 Published: 2006 Times Cited: 283 DOI: 10.1158/0008-5472.can-06-1500
added
02-Dec-11
9.
Title: MDA-468, A HUMAN-BREAST CANCER CELL-LINE WITH A HIGH NUMBER OF EPIDERMAL GROWTH-FACTOR (EGF) RECEPTORS, HAS AN AMPLIFIED EGF RECEPTOR GENE AND IS GROWTH INHIBITED BY EGF Author(s): Filmus, J.; Pollak, M. N.; Cailleau, R.; et al. Source: Biochemical and Biophysical Research Communications Volume: 128 Issue: 2 Pages: 898-905 Published: 1985 Times Cited: 274 DOI: 10.1016/0006-291x(85)90131-7
added
01-Dec-11
10.
Title: Insulin-like growth factor-I (IGF-I) and IGF binding protein-3 as predictors of advanced-stage prostate cancer Author(s): Chan, J. M.; Stampfer, M. J.; Ma, J.; et al. Source: Journal of the National Cancer Institute Volume: 94 Issue: 14 Pages: 1099-1106 Published: 2002 Times Cited: 273
